Home Newsletters Dermal Cell News Topical Application of Imatinib Mesylate Ameliorated Psoriasis-Like Skin Lesions in Imiquimod-Induced Murine...

Topical Application of Imatinib Mesylate Ameliorated Psoriasis-Like Skin Lesions in Imiquimod-Induced Murine Model via Angiogenesis Inhibition

0
Hyperproliferation of keratinocytes, hyperkeratosis, inflammatory cell infiltration and hypervascularity were histologically suppressed by topical imatinib mesylate. The expression of angiogenic factors including fibroblast growth factor and vascular endothelial growth factor was decreased.
[Experimental Dermatology]
Abstract
Exit mobile version